Wuhan Hiteck Biological Pharma Co., Ltd.

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

It promotes the conversion of fibrinogen into fibrin, which is applied to wounds to coagulate blood and stop bleeding.

Immune bidirectional regulatory drug. It has the function of inducing and promoting the differentiation, maturation and activation of T lymphocytes and their subgroups, regulating the ratio of T lymphocytes to make CD4/CD8 tend to normal; regulating and enhancing the cellular immune function of the human body, which can promote the maturation of T lymphocytes in peripheral blood after mitogen activation, increase the secretion of various lymphokines (such as alpha, gamma interferon, interleukin 2 or interleukin 3) after T cells are activated by various antigens or mitogens, and increase the level of lymphokine receptors on T cells. It also enhances lymphocyte response by activating T helper cells. In addition, this product may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon, which is conducive to its therapeutic effect. In addition, this product can enhance the body's ability to resist radiation.

Cytidine triphosphate disodium is a coenzyme drug and a nucleotide derivative. It participates in the synthesis and metabolism of phospholipids and nucleic acids in the body. It is an intermediate product and energy source for brain phospholipid synthesis and nucleic acid metabolism.

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.